Date Filed | Type | Description |
07/19/2022 |
4
| Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Exercised 20,063 options to buy
@ $0.45, valued at
$9k
|
|
05/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2022 |
4
| Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
12/29/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Bought 66,907 shares
@ $2.5486, valued at
$170.5k
Bought 210,337 shares
@ $2.6617, valued at
$559.9k
|
|
12/22/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Bought 3,527 shares
@ $2.5449, valued at
$9k
|
|
12/20/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Bought 27,883 shares
@ $2.5461, valued at
$71k
Bought 13,742 shares
@ $2.5439, valued at
$35k
|
|
12/17/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns:
| Paid exercise price by delivering 41,091 shares
@ $13.78, valued at
$566.2k
Bought 77,604 shares
@ $2.4091, valued at
$187k
|
|
09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/22/2020 |
4
| Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Disposed of 993,801 shares
@ $0 Acquired 181,024 shares
@ $0 |
|
07/08/2020 |
4
| Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns:
| Exercised 9,310 options to buy
@ $0.65, valued at
$6.1k
Exercised 12,930 options to buy
@ $1.03, valued at
$13.3k
|
|
06/08/2020 |
4
| Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns:
| Granted 21,693 options to buy
@ $2.79, valued at
$60.5k
|
|
01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2019 |
4
| Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns:
| Granted 21,693 options to buy
@ $2.78, valued at
$60.3k
|
|
01/22/2019 |
4
| Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Bought 190,875 shares
@ $5.37, valued at
$1M
Bought 74,441 warrants
@ $12.74, valued at
$948.4k
|
|
01/04/2019 |
4
| Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 7,650 options to buy
@ $0 |
|
06/21/2018 |
4
| Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns:
| Granted 21,693 options to buy
@ $5.82, valued at
$126.3k
|
|
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/28/2017 |
4
| Venkatesan Jay (Director) has filed a Form 4 on Max-1 Acquisition Corp
Txns:
| Acquired 190,957 shares
@ $0 Acquired 90,192 shares
@ $0 Granted 52,234 shares
@ $0 Bought 66,666 shares
@ $3, valued at
$200k
Granted 9,309 options to buy
@ $0 Granted 12,929 options to buy
@ $0 Granted 24,824 options to buy
@ $0 |
|
09/28/2017 |
3
| Venkatesan Jay (Director) has filed a Form 3 on Max-1 Acquisition Corp |
07/26/2017 |
4
| Venkatesan Jay (President) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Acquired 18,633 shares
@ $0 Granted 21,739 shares
@ $0 Acquired 3,803,906 shares
@ $0 Granted 90,063 options to buy
@ $0 |
|
07/26/2017 |
3
| Venkatesan Jay (President) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/16/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/16/2014 |
4
| Venkatesan Jay (EVP and General Manager) has filed a Form 4 on Oncothyreon Inc.
Txns:
| Granted 100,000 options to buy
@ $1.76, valued at
$176k
|
|
|